Maureen D. McKelvey
- Published in print:
- 2000
- Published Online:
- October 2011
- ISBN:
- 9780198297246
- eISBN:
- 9780191685316
- Item type:
- chapter
- Publisher:
- Oxford University Press
- DOI:
- 10.1093/acprof:oso/9780198297246.003.0008
- Subject:
- Business and Management, Innovation, Knowledge Management
This chapter examines the interdependencies between knowledge-seeking activities and agents setting environmental conditions over the definitions of multiple uses of, and markets for, the ...
More
This chapter examines the interdependencies between knowledge-seeking activities and agents setting environmental conditions over the definitions of multiple uses of, and markets for, the pharmaceutical human growth hormone. Pituitary hGH was approved to treat a condition called hypopituitary dwarfism. This chapter has concentrated on knowledge-seeking activities directly affecting or creating uses of, and markets for, hGH. Much of the focus has been on how firms identified and used technical and economic criteria to direct their activities to conform to existing criteria, and in the process create new, social selection criteria. The firms had incentives to invest in knowledge-seeking activities to generate legitimate uses of the pharmaceutical. In the best case, medical research would show multiple uses (indications) or else expand the range of uses for existing indications. The generation and selection of uses and markets for pharmaceutical hGH has depended on negotiations and interactions particularly among producer firms, medical researchers, and government regulatory agencies.Less
This chapter examines the interdependencies between knowledge-seeking activities and agents setting environmental conditions over the definitions of multiple uses of, and markets for, the pharmaceutical human growth hormone. Pituitary hGH was approved to treat a condition called hypopituitary dwarfism. This chapter has concentrated on knowledge-seeking activities directly affecting or creating uses of, and markets for, hGH. Much of the focus has been on how firms identified and used technical and economic criteria to direct their activities to conform to existing criteria, and in the process create new, social selection criteria. The firms had incentives to invest in knowledge-seeking activities to generate legitimate uses of the pharmaceutical. In the best case, medical research would show multiple uses (indications) or else expand the range of uses for existing indications. The generation and selection of uses and markets for pharmaceutical hGH has depended on negotiations and interactions particularly among producer firms, medical researchers, and government regulatory agencies.
